Cerepar
Brand names,
Cerepar
Analogs
Cerepar
Brand Names Mixture
Cerepar
Chemical_Formula
C26H28N2
Cerepar
RX_link
No information avaliable
Cerepar
fda sheet
Cerepar
msds (material safety sheet)
Cerepar
Synthesis Reference
No information avaliable
Cerepar
Molecular Weight
368.514 g/mol
Cerepar
Melting Point
No information avaliable
Cerepar
H2O Solubility
750 mg/L
Cerepar
State
Solid
Cerepar
LogP
5.63
Cerepar
Dosage Forms
No information avaliable
Cerepar
Indication
For the treatment of vertigo/meniere's disease, nausea and vomiting, motion sickness and also useful for vestibular symptoms of other origins.
Cerepar
Pharmacology
Cinnarizine is an antihistamine and a calcium channel blocker. Histamines mediate a number of activities such as contraction of smooth muscle of the airways and gastrointestinal tract, vasodilatation, cardiac stimulation, secretion of gastric acid, promotion of interleukin release and chemotaxis of eosinophils and mast cells. Competitive antagonists at histamine H1 receptors may be divided into first (sedating) and second (non-sedating) generation agents. Some, such as Cinnarizine also block muscarinic acetylcholine receptors and are used as anti-emetic agents. Cinnarizine through its calcium channel blocking ability also inhibits stimulation of the vestibular system.
Cerepar
Absorption
No information avaliable
Cerepar
side effects and Toxicity
No information avaliable
Cerepar
Patient Information
No information avaliable
Cerepar
Organisms Affected
Humans and other mammals